Be The Match BioTherapies - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $80,368.80 +5.19%
Ethereum $3,213.24 +4.18%
BNB $634.24 +2.86%
Optimism $1.67 +5.39%
Arbitrum $0.64 +7.35%
Solana $210.67 +6.09%
Polygon $0.42 +11.07%
Cosmos $5.44 +15.53%
Avalanche $32.58 +12.30%

Bitcoin $80,368.80 +5.19%
Ethereum $3,213.24 +4.18%
BNB $634.24 +2.86%
Optimism $1.67 +5.39%
Arbitrum $0.64 +7.35%
Solana $210.67 +6.09%
Polygon $0.42 +11.07%
Cosmos $5.44 +15.53%
Avalanche $32.58 +12.30%

Be The Match BioTherapies

investment firm

Summary
Investments
Exits
Employees

About

Be The Match BioTherapies® is built on the foundation established by our parent company.

https://bethematchbiotherapies.com/

Highlights

Employee Profiles

Details

Operating Status: Active

Investments

Number of Investments

Number of Lead Investments

5

0

Be The Match BioTherapies has made 5 investments. Their most recent investment was on Oct 31, 2019, when Tmunity Therapeutics raised $75M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Oct 31, 2019 Tmunity Therapeutics	Series B	$75M	Biotechnology	—
Apr 19, 2018 Tmunity Therapeutics	Series A	$35M	Biotechnology	—
Apr 9, 2018 Magenta Therapeutics	Series C	$52M	Biotechnology	—
Jan 23, 2018 Tmunity Therapeutics	Series A	$100M	Biotechnology	—
May 2, 2017 Magenta Therapeutics	Series B	$50M	Biotechnology	—

Employee Profiles

Number of Employee Profiles

2

Be The Match BioTherapies has 2 current employee profiles, including Executive Chris McClain

Executive

Executive

Exits

Be The Match BioTherapies has had 2 exits. Be The Match BioTherapies most notable exits include Tmunity Therapeutics , Magenta Therapeutics

Date	Company Name	Exit Type	Industry
Dec 20, 2022	Tmunity Therapeutics	M&A	Biotechnology	Detail
Jun 20, 2018	Magenta Therapeutics	IPO	Biotechnology	Detail